A Dose-escalation Study of Xeloda Plus Radiation Therapy in Pediatric Patients With Newly Diagnosed Non-disseminated, Intrinsic Brainstem Gliomas and High Grade Gliomas.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
MTD and DLT, measured by clinical and neurological examination, AEs, laboratory parameters.
United States: Food and Drug Administration
|Hinsdale, Illinois 60521|
|Fountain Valley, California 92708|
|Philadelphia, Pennsylvania 19104|
|Austin, Texas 78705|
|Seattle, Washington 98195|
|Charlotte, North Carolina|
|Washington, District of Columbia|